[Combined use of amifostine and misonidazole in experimental radiotherapy].
D004999:Amifostine / Q000008:administration & dosage*; D000818:Animals; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000532:radiotherapy*; D051379:Mice; D008809:Mice, Inbred C3H; D008920:Misonidazole / Q000008:administration & dosage*; D009593:Nitroimidazoles / Q000008:administration & dosage*; D009946:Organothiophosphorus Compounds / Q000008:administration & dosage*; D011837:Radiation-Protective Agents / Q000008:administration & dosage*
D009593:Nitroimidazoles; D009946:Organothiophosphorus Compounds; D011837:Radiation-Protective Agents; D008920:Misonidazole; D004999:Amifostine